Houston, TX, February 23, 2011
OrthoAccel® Technologies, Inc. developers of the AcceleDent™ System, a medical device to accelerate orthodontic treatment, announced this week that it has engaged Dr. Dawei Liu as a scientific advisor. Dr. Liu’s guidance and expertise will help advance the Company’s commitment to a research-focused strategy for developing and introducing innovative new products.
AcceleDent™ is a simple, removable dental appliance that an orthodontic patient wears in the mouth for 20 minutes daily to accelerate orthodontic tooth movement. A Phase I clinical trial in 2008 in Houston, Texas demonstrated the safety and clinical utility of the device. first completed AcceleDent™ case in private practice was documented last November in the United Kingdom. Dr. Liu’s background is particularly relevant to OrthoAccel®’s focus. His extensive research has centered around the investigation of the effects of mechanical vibration on orthodontic tooth movement, in an attempt to shorten the total treatment time and reduce the risk of root resorption in clinical orthodontic patients. Previously, he accepted an invitation from Dr. Birte Melsen to work as a Clinical Assistant Professor at the Department of Orthodontics at the Royal Dental College in Denmark. Currently, he is the pre-doctoral Program Director and Research Director at Marquette University in the Department of Developmental Sciences / Orthodontics.
Michael Lowe, CEO of OrthoAccel®, commented, “At OrthoAccel®, we are always looking for ways to improve our technologies, and to provide the most scientifically advanced products to our customers. Dr. Liu’s scientific research compliments OrthoAccel®’s objectives. We believe that he can effectively guide us toward establishing an evidence-based foundation, which is an important objective.” Dr. Liu remarked, “AcceleDent™ has the potential to revolutionize orthodontics and I am looking forward to working with Management to help guide OrthoAccel®’s future scientific research strategy.”
OrthoAccel®’s Management team is traveling to Europe next month to work on commercialization efforts in several key markets.
OrthoAccel® has completed a pivotal US clinical trial at the UT Health Science Center in San Antonio , and is planning a submission for FDA clearance on AcceleDent™ later this month.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent™ System
AcceleDent™ represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent™ is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via email@example.com
Media Contact Michael K. Lowe, CEO +1 (832) 631-1659